Table 2.
Peptide sequence | MH+ | z | P (pep) | XC | ΔCn |
---|---|---|---|---|---|
AAPLSRDPTEVTAIGAVEAAFKC@CAAAIIVLTT | 3323.82 | 3 | 1.01E-05 | 3.72 | 0.36 |
AAPLSRDPTEVTAIGAVEAAFKC#C#AAAIIVLTTTGR | 3704.27 | 3 | 2.81E-12 | 8.21 | 0.58 |
C@C@AAAIIVLTTTGR | 1489.70 | 2 | 7.17E-05 | 2.68 | 0.35 |
C#C#AAAIIVLTTTGR | 1507.80 | 2 | 1.24E-06 | 3.93 | 0.42 |
L-PYK was subjected to iodoamide alkylation previously to its overnight treatment with trypsin at 37°C. The resulting peptides were analyzed by HPLC-MS/MS on an LTQ-FT mass spectrometer. C# stands for carboxymethylcysteine; C@ stands for Cysteine sulfonic acid. Tandem mass spectra were searched against a human protein database using the Sequest algorithm and the following parameters for protein ID: peptide probability of random match <10-3, XC ≥ 1.9, 2.5 or 3.5 for z=1, 2 or 3 respectively and ΔCn ≥ 0.1. Peptides containing oxydized Cys are highlited in boldface. Since C# denoted cysteines were reactive modified by alkylation, they were not irreversibly oxidized.